Immediate order for 1,500 additional spencer® devices from Spencer Health Solutions for Catalyst Healthcare’s network to connect through telehealth with Canada’s most vulnerable patients
Spencer Health CEO Tom Rhoads lays a road-map for integrating telehealth in clinical research and value-based care. COVID-19 is accelerating much-needed healthcare and clinical research transformation to focus on the patients first. This global pandemic is pressing the gas pedal hard as people are challenged to receive their medications and stay connected with their healthcare providers … Continue reading It’s Time to Integrate Telehealth into the Equation
With so much information circulating about the Coronavirus, or COVID-19, we realize that our spencer® patients may be considering additional steps you might take to keep yourself and your family healthy and safe.
Three years in the market, the spencer Direct-to-Patient platform is consistently demonstrating a new standard of greater than 95% adherence among chronically-ill patients.
Royal Philips and Spencer Health Solutions expand partnership to Europe. Chronically ill patients in selected EU countries to benefit from in-home medication adherence and telehealth platform.
Spencer Health Solutions, Inc., a leader in home-based healthcare technology, today announced the launch of its new podcast series People Always, Patients Sometimes.
USA Today published an article on wearable devices that addressed a real concern for physicians. Wearable devices can provide a lot of data but clinicians don’t know what to do with it.
Medication adherence plays a substantial role in the success of clinical trials, according to data presented in a new white paper issued by Spencer Health Solutions.
Spencer Health Solutions, Inc. today introduced the spencer® full-circle patient engagement and medication adherence solution to clinical research during the eyeforpharma conference being held in Philadelphia.
FOR IMMEDIATE RELEASE: Non-adherence in clinical trials drives operational costs significantly higher96% of spencer users are adherent; and reducing non-adherence in trials by just 1% can reduce costs by up to $300KPatient-reported outcomes (PRO) gathered through spencer offer pharma, regulators and payers a new way to study the impact of an investigational drug on a … Continue reading spencer® Technology in Clinical Research Offers Greater Adherence to Trial Drugs, Lower Costs